UY27118A1 - Método de producción de vacuna combinada - Google Patents
Método de producción de vacuna combinadaInfo
- Publication number
- UY27118A1 UY27118A1 UY27118A UY27118A UY27118A1 UY 27118 A1 UY27118 A1 UY 27118A1 UY 27118 A UY27118 A UY 27118A UY 27118 A UY27118 A UY 27118A UY 27118 A1 UY27118 A1 UY 27118A1
- Authority
- UY
- Uruguay
- Prior art keywords
- present
- convulsa
- tetanus
- diphtheria
- cough
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A61K39/0017—Combination vaccines based on whole cell diphtheria-tetanus-pertussis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención trata un método para la producción de una vacuna combinada capaz de prevenir concurrentemente múltiples enfermedades como la difteria, el tétanos, la tos convulsa y la hepatitis B que deben prevenirse en el nino. El método para producir una vacuna combinada de acuerdo con la presente invención incluye los pasos de adsorber independientemente cada antígeno protector a un adsorbente de gel de hidróxido de aluminio respecto a diversas enfermedades como la difteria, el tétanos, la tos convulsa y la hepatitis B que deben prevenirse en los ninos y combinar cada antígeno protector adsorbido al adsorbente después de la adsorción. En la presente invención, es posible prevenir concurrentemente enfermedades múltiples como la difteria, el tétanos, la tos convulsa y la hepatitis B que deben prevenirse en el nino usando una vacuna combinada producida de acuerdo con la presente invención.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2001-0001290A KR100401423B1 (ko) | 2001-01-10 | 2001-01-10 | 혼합 백신의 제조 방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY27118A1 true UY27118A1 (es) | 2002-08-30 |
Family
ID=19704448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY27118A UY27118A1 (es) | 2001-01-10 | 2002-01-09 | Método de producción de vacuna combinada |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20040048336A1 (es) |
| EP (1) | EP1349572B1 (es) |
| JP (1) | JP3977257B2 (es) |
| KR (1) | KR100401423B1 (es) |
| CN (1) | CN1228086C (es) |
| AR (1) | AR032391A1 (es) |
| AT (1) | ATE373485T1 (es) |
| AU (1) | AU2002219693B2 (es) |
| BR (1) | BR0206391A (es) |
| CA (1) | CA2434421C (es) |
| DE (1) | DE60222529T2 (es) |
| ES (1) | ES2291466T3 (es) |
| IL (1) | IL156791A0 (es) |
| MX (1) | MXPA03006154A (es) |
| MY (1) | MY143688A (es) |
| PE (1) | PE20020758A1 (es) |
| PL (1) | PL211005B1 (es) |
| RU (1) | RU2264226C2 (es) |
| UY (1) | UY27118A1 (es) |
| WO (1) | WO2002055105A1 (es) |
| ZA (1) | ZA200305072B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA40596C2 (uk) | 1992-05-23 | 2001-08-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини та спосіб її одержання |
| GB0505996D0 (en) | 2005-03-23 | 2005-04-27 | Glaxosmithkline Biolog Sa | Fermentation process |
| GB0522765D0 (en) * | 2005-11-08 | 2005-12-14 | Chiron Srl | Combination vaccine manufacture |
| CN101460180B (zh) * | 2006-05-31 | 2012-06-27 | 西尔维奥·布齐 | 与白喉毒素免疫相关的蛋白质分子的药物应用 |
| GB0616306D0 (en) * | 2006-08-16 | 2006-09-27 | Novartis Ag | Vaccines |
| WO2008028957A2 (en) * | 2006-09-07 | 2008-03-13 | Glaxosmithkline Biologicals S.A. | Vaccine |
| GB0822633D0 (en) * | 2008-12-11 | 2009-01-21 | Novartis Ag | Formulation |
| IT1398927B1 (it) | 2009-06-25 | 2013-03-28 | Consorzio Interuniversitario Per Lo Sviluppo Dei Sistemi A Grande Interfase Csgi | Espressione batterica di un gene artificiale per la produzione di crm197 e derivati. |
| GB0917647D0 (en) | 2009-10-08 | 2009-11-25 | Glaxosmithkline Biolog Sa | Expression system |
| CN102363041A (zh) * | 2011-11-17 | 2012-02-29 | 成都欧林生物科技股份有限公司 | 不含防腐剂疫苗的制作工艺 |
| KR101518473B1 (ko) | 2013-03-14 | 2015-05-07 | (주)바이오인디스트 | 애완견의 바이러스성 전염병 예방 및 치료용 복합 난황 항체 조성물 및 그 제조방법 |
| AR102547A1 (es) * | 2014-11-07 | 2017-03-08 | Takeda Vaccines Inc | Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso |
| AU2015252119A1 (en) | 2014-11-07 | 2016-05-26 | Takeda Vaccines, Inc. | Hand, foot, and mouth vaccines and methods of manufacture and use thereof |
| KR20220076405A (ko) * | 2020-11-30 | 2022-06-08 | 주식회사 엘지화학 | 알루미늄 부형제를 이용하여 다가 혼합백신 내 백일해 균 유래 엔도톡신 제거 방법 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU188847B (en) * | 1983-02-22 | 1986-05-28 | Human Oltoanyagtermeloe Es Kutato Intezet,Hu | Process for producing liophylized combined vaccines |
| CA1213234A (en) * | 1983-03-30 | 1986-10-28 | Akihiro Ginnaga | Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine |
| US4649192A (en) * | 1985-05-30 | 1987-03-10 | Smith Kline-Rit | Method for the isolation and purification of hepatitis B surface antigen using polysorbate |
| ES2061500T5 (es) * | 1986-06-17 | 2003-05-16 | Chiron Corp | Diagnosis y vacunas de la hepatitis delta, su preparacion y uso. |
| JPH085804B2 (ja) * | 1988-04-28 | 1996-01-24 | 財団法人化学及血清療法研究所 | Ａ型及びｂ型肝炎混合アジュバントワクチン |
| EP0484621A3 (en) * | 1990-07-11 | 1992-08-26 | American Cyanamid Company | Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
| UA40596C2 (uk) * | 1992-05-23 | 2001-08-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини та спосіб її одержання |
| JP4229341B2 (ja) * | 1996-03-23 | 2009-02-25 | 財団法人阪大微生物病研究会 | 破傷風毒素の機能的フラグメント抗原及び破傷風ワクチン |
| GB9611501D0 (en) * | 1996-06-03 | 1996-08-07 | Smithkline Beecham Biolog | Vaccine compositions |
| TR199802783T2 (xx) * | 1996-07-02 | 1999-03-22 | Connaught Laboratories Limited | �ok de�erli DTP polyo a��lar. |
| GB9623233D0 (en) * | 1996-11-07 | 1997-01-08 | Smithkline Beecham Biolog | Vaccine composition |
| DE69735191T2 (de) * | 1997-09-15 | 2006-10-05 | Sanofi Pasteur Msd | Verfahren zur Herstellung multivalenter Impfstoffe |
| GB9806456D0 (en) * | 1998-03-25 | 1998-05-27 | Smithkline Beecham Biolog | Vaccine composition |
-
2001
- 2001-01-10 KR KR10-2001-0001290A patent/KR100401423B1/ko active IP Right Grant
-
2002
- 2002-01-08 MY MYPI20020056A patent/MY143688A/en unknown
- 2002-01-09 CA CA2434421A patent/CA2434421C/en not_active Expired - Fee Related
- 2002-01-09 EP EP02729589A patent/EP1349572B1/en not_active Revoked
- 2002-01-09 RU RU2003124660/15A patent/RU2264226C2/ru active
- 2002-01-09 US US10/465,930 patent/US20040048336A1/en not_active Abandoned
- 2002-01-09 MX MXPA03006154A patent/MXPA03006154A/es active IP Right Grant
- 2002-01-09 PL PL369433A patent/PL211005B1/pl not_active IP Right Cessation
- 2002-01-09 ES ES02729589T patent/ES2291466T3/es not_active Expired - Lifetime
- 2002-01-09 AR ARP020100060A patent/AR032391A1/es unknown
- 2002-01-09 JP JP2002555838A patent/JP3977257B2/ja not_active Expired - Fee Related
- 2002-01-09 UY UY27118A patent/UY27118A1/es not_active IP Right Cessation
- 2002-01-09 AT AT02729589T patent/ATE373485T1/de not_active IP Right Cessation
- 2002-01-09 DE DE60222529T patent/DE60222529T2/de not_active Revoked
- 2002-01-09 PE PE2002000008A patent/PE20020758A1/es active IP Right Grant
- 2002-01-09 WO PCT/KR2002/000034 patent/WO2002055105A1/en active IP Right Grant
- 2002-01-09 AU AU2002219693A patent/AU2002219693B2/en not_active Ceased
- 2002-01-09 BR BR0206391-3A patent/BR0206391A/pt active Search and Examination
- 2002-01-09 CN CNB028035933A patent/CN1228086C/zh not_active Expired - Fee Related
-
2003
- 2003-01-09 IL IL15679103A patent/IL156791A0/xx not_active IP Right Cessation
- 2003-06-30 ZA ZA200305072A patent/ZA200305072B/en unknown
-
2009
- 2009-03-19 US US12/407,445 patent/US20090181050A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR0206391A (pt) | 2004-07-27 |
| MXPA03006154A (es) | 2003-09-16 |
| CN1228086C (zh) | 2005-11-23 |
| ES2291466T3 (es) | 2008-03-01 |
| AR032391A1 (es) | 2003-11-05 |
| RU2264226C2 (ru) | 2005-11-20 |
| KR20020060298A (ko) | 2002-07-18 |
| IL156791A0 (en) | 2004-02-08 |
| AU2002219693B2 (en) | 2006-03-16 |
| PL211005B1 (pl) | 2012-03-30 |
| EP1349572A4 (en) | 2004-09-15 |
| DE60222529T2 (de) | 2008-06-19 |
| ATE373485T1 (de) | 2007-10-15 |
| CA2434421C (en) | 2012-02-21 |
| ZA200305072B (en) | 2003-09-17 |
| DE60222529D1 (de) | 2007-10-31 |
| PL369433A1 (en) | 2005-04-18 |
| US20090181050A1 (en) | 2009-07-16 |
| US20040048336A1 (en) | 2004-03-11 |
| JP3977257B2 (ja) | 2007-09-19 |
| MY143688A (en) | 2011-06-30 |
| JP2004517866A (ja) | 2004-06-17 |
| RU2003124660A (ru) | 2005-01-10 |
| PE20020758A1 (es) | 2002-08-29 |
| CN1484531A (zh) | 2004-03-24 |
| EP1349572A1 (en) | 2003-10-08 |
| WO2002055105A1 (en) | 2002-07-18 |
| CA2434421A1 (en) | 2002-07-18 |
| KR100401423B1 (ko) | 2003-10-17 |
| EP1349572B1 (en) | 2007-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY27118A1 (es) | Método de producción de vacuna combinada | |
| PL1635863T3 (pl) | Kompozycje do wywoływania, wzmacniania i utrzymywania odpowiedzi immunologicznych na epitopy ograniczone do MHC klasy I do celów profilaktycznych i leczniczych | |
| BRPI0306905B8 (pt) | método de produção de uma composição imunogênica/dengue que compreende um flavivírus | |
| TW200518209A (en) | Transparent amorphous carbon structure in semiconductor devices | |
| AR073959A1 (es) | Vacuna de combinacion con tos ferina acelular y metodo para su elaboracion | |
| AR014762A1 (es) | PROCEDIMIENTO PARA REDUCIR LA INTERFERENCIA DE COMPONENTES POLISACARIDOS CAPSULARES, DE VACUNAS CONJUGADAS DE HAEMOPHILUS INFLUENZAE B (Hib) EN VACUNASDE COMBINACION, VACUNAS DE COMBINACION OBTENIDAS CON DICHO PROCEDIMIENTO DE VACUNACION CONTRA LA DIFTERIA, TETANO, PERTUSSIS Y HAEMOPHILUS INFLUENZAE | |
| WO2012012245A3 (en) | Led lamp for producing biologically-corrected light | |
| SG158154A1 (en) | Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes | |
| ECSP056014A (es) | MOLÉCULAS DE ANTICUERPOS QUE TIENEN ESPECIFICIDAD PARA IL-1ß HUMANA | |
| UY29173A1 (es) | Oligonucleótidos inmunoestimuladores de clase c semiblandos | |
| CY1108521T1 (el) | Παρασκευη αλδεσλευκινης για φαρμακευτικη χρηση | |
| DE602005027469D1 (de) | Pharmazeutische zusammensetzung mit verzögerter freisetzung aus tolterodin | |
| DE69840911D1 (de) | Gelierte zusammensetzungen | |
| AR048830A1 (es) | Preparado polifasico para la contracepcion a base de un estrogeno natural y un gestageno sintetico | |
| AR039982A1 (es) | Composicion vacunal contra las alergias, metodo para su obtencion y empleo en el tratamiento de las mismas | |
| WO2006021908A3 (en) | Lamp | |
| DK1515732T3 (da) | Cerebral protektion med en xenonholdig gas | |
| TH61084A (th) | วิธีการผลิตวัคซีนรวม | |
| CHANG et al. | Response of desert climate change to global warming in Minqin, China | |
| AR023536A1 (es) | Vacunas | |
| CU23496A1 (es) | Composición vacunal contra el virus de la hepatitis c | |
| Moloney | St. Thomas and Spenser's Virtue of Magnificence | |
| AR027738A1 (es) | Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunas | |
| TWD166383S (zh) | ３６０度ｌｅｄ燈芯柱（四） | |
| KR200222934Y1 (ko) | 소켓내부에 안정기를 내장한 형광등기구 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 110 | Patent granted |
Effective date: 20151113 |
|
| VENC | Patent expired |
Effective date: 20220109 |